We provide you with 20 years of free, institutional-grade data for VRTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VRTX. Explore the full financial landscape of VRTX stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-06 | 1806837 | VRTX | 10-Q | Url |
2025-05-07 | 1806837 | VRTX | 10-Q | Url |
2025-02-27 | 1806837 | VRTX | 10-K | Url |
2024-11-06 | 1806837 | VRTX | 10-Q | Url |
2024-08-07 | 1806837 | VRTX | 10-Q | Url |
2024-05-08 | 1806837 | VRTX | 10-Q | Url |
2024-02-29 | 1806837 | VRTX | 10-K | Url |
2023-11-09 | 1806837 | VRTX | 10-Q | Url |
2023-08-09 | 1806837 | VRTX | 10-Q | Url |
2023-05-10 | 1806837 | VRTX | 10-Q | Url |
2023-03-10 | 1806837 | VRTX | 10-K | Url |
2022-11-09 | 1806837 | VRTX | 10-Q | Url |
2022-08-09 | 1806837 | VRTX | 10-Q | Url |
2022-05-10 | 1806837 | VRTX | 10-Q | Url |
2022-03-16 | 1806837 | VRTX | 10-K | Url |
2021-11-12 | 1806837 | VRTX | 10-Q | Url |
2021-08-12 | 1806837 | VRTX | 10-Q | Url |
2021-05-13 | 1806837 | VRTX | 10-Q | Url |
2021-03-15 | 1806837 | VRTX | 10-K | Url |
2020-11-13 | 1806837 | VRTX | 10-Q | Url |
2020-09-11 | 1806837 | VRTX | 10-Q | Url |
2020-07-02 | 1806837 | VRTX | S-1 | Url |
Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX)


Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regul...
Website: http://www.vrtx.com
Founded: 1989
Full Time Employees: 3,000
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VRTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.